Related Experiment Videos
[Expression with TGFbeta1 in the patients with ulcerative colitis]
Yu-fang Wang1, Bing Wei, Qin Ouyang
1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China.
Summary
Transforming growth factor beta 1 (TGFbeta1) is elevated in ulcerative colitis (UC) and infectious colitis (IC) but does not control inflammation, suggesting TGFbeta1 signaling defects in UC. This indicates TGFbeta1 may be a UC disease activity marker.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Context:
- Ulcerative colitis (UC) and infectious colitis (IC) are inflammatory conditions affecting the colon.
- Understanding the molecular mechanisms underlying these conditions is crucial for effective treatment.
Purpose:
- To investigate the differential expression of transforming growth factor beta 1 (TGFbeta1) and its mRNA in the colonic mucosa of patients with UC, IC, and healthy controls.
Summary:
- Immunohistochemistry and in situ hybridization revealed significantly higher TGFbeta1 and TGFbeta1 mRNA expression in both UC and IC groups compared to normal controls.
- No significant difference in TGFbeta1 expression was observed between UC and IC groups.
- TGFbeta1 expression in UC correlated positively with histological grade, suggesting its role in disease severity.
Impact:
- The findings suggest that while TGFbeta1 is upregulated in UC, it fails to inhibit pro-inflammatory cytokines, pointing to potential TGFbeta1 signaling defects in UC pathogenesis.
- TGFbeta1 may serve as a valuable biomarker for assessing ulcerative colitis disease activity.